Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
暂无分享,去创建一个
C. Dobson | M. Vendruscolo | F. Chiti | J. Habchi | T. Knowles | Catherine K. Xu | B. Mannini | C. Cecchi | R. Cascella | Ryan Limbocker | Michele Perni | F. Ruggeri | J. Kumita | D. Barbut | G. Meisl | Ryan P. Kreiser | Aidan K. Wright | Jared E. Hollows | Lam Nguyen | K. LeForte | Patrick Flagmeier | A. Bigi | T. Kartanas | Sean Chia | Roxine Staats | Silvia Errico | M. Zasloff | Liam R. Sasser | Natalie R. Block | Edward T. Custy | Natalie Block
[1] A. Sickmann,et al. eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction. , 2021, Cell reports.
[2] H. Tilg,et al. Dietary spermidine improves cognitive function. , 2021, Cell reports.
[3] Romain F. Laine,et al. Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease , 2021, Frontiers in Cell and Developmental Biology.
[4] M. Vendruscolo,et al. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases , 2021, Nature Reviews Chemistry.
[5] M. Vendruscolo,et al. Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers , 2020, International journal of molecular sciences.
[6] M. Vendruscolo,et al. Making biological membrane resistant to the toxicity of misfolded protein oligomers: a lesson from trodusquemine. , 2020, Nanoscale.
[7] D. Otzen,et al. Inhibitors of α-Synuclein fibrillation and oligomer toxicity in Rosa damascena: the all-pervading powers of flavonoids and phenolic glycosides. , 2020, ACS chemical neuroscience.
[8] C. Dobson,et al. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism , 2020, Communications Biology.
[9] C. Dobson,et al. Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers , 2020, International journal of molecular sciences.
[10] A. Šarić,et al. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide , 2020, bioRxiv.
[11] C. Dobson,et al. Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies , 2019, ACS chemical biology.
[12] C. Dobson,et al. Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes , 2019, Nature Communications.
[13] C. Dobson,et al. SAR by kinetics for drug discovery in protein misfolding diseases , 2018, Proceedings of the National Academy of Sciences.
[14] C. Dobson,et al. Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity , 2018, Nature Communications.
[15] C. Dobson,et al. Structural differences between toxic and nontoxic HypF-N oligomers. , 2018, Chemical communications.
[16] C. Dobson,et al. Stabilization and Characterization of Cytotoxic Aβ40 Oligomers Isolated from an Aggregation Reaction in the Presence of Zinc Ions. , 2018, ACS chemical neuroscience.
[17] J. B. Kirkegaard,et al. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine. , 2018, ACS chemical biology.
[18] C. Dobson,et al. Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes , 2018, Nature Chemistry.
[19] C. Dobson,et al. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers , 2017, Science.
[20] C. Dobson,et al. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.
[21] Michele Vendruscolo,et al. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method , 2017, Science Advances.
[22] T. Rando,et al. The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues , 2017, npj Regenerative Medicine.
[23] Michele Vendruscolo,et al. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity , 2017, Proceedings of the National Academy of Sciences.
[24] Zhefeng Guo,et al. Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation , 2017, Royal Society Open Science.
[25] Tuomas P. J. Knowles,et al. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease , 2016, Proceedings of the National Academy of Sciences.
[26] C. Dobson,et al. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases , 2016, Scientific Reports.
[27] Alexander K. Buell,et al. Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation , 2016, Proceedings of the National Academy of Sciences.
[28] H. Lashuel,et al. Nanoscale studies link amyloid maturity with polyglutamine diseases onset , 2016, Scientific Reports.
[29] Alexander K. Buell,et al. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein , 2016, Proceedings of the National Academy of Sciences.
[30] C. Dobson,et al. Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations , 2016, Biological chemistry.
[31] Michele Vendruscolo,et al. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease , 2016, Science Advances.
[32] M. C. Graber,et al. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity. , 2016, Biochemistry.
[33] C. Dobson,et al. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation , 2015, Proceedings of the National Academy of Sciences.
[34] C. Dobson,et al. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. , 2015, Nature chemical biology.
[35] Giovanni Dietler,et al. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization. , 2015, Angewandte Chemie.
[36] Michele Vendruscolo,et al. The molecular chaperone Brichos breaks the catalytic cycle that generates toxic Aβ oligomers , 2015, Nature Structural &Molecular Biology.
[37] C. Dobson,et al. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. , 2014, ACS chemical biology.
[38] J. Cummings,et al. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.
[39] Tuomas P. J. Knowles,et al. The amyloid state and its association with protein misfolding diseases , 2014, Nature Reviews Molecular Cell Biology.
[40] Daniel H. Miller,et al. Targeting the disordered C-terminus of PTP1B with an allosteric inhibitor , 2014, Nature chemical biology.
[41] Michele Vendruscolo,et al. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.
[42] Michele Vendruscolo,et al. Chemical kinetics for drug discovery to combat protein aggregation diseases. , 2014, Trends in pharmacological sciences.
[43] Michele Vendruscolo,et al. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.
[44] Michele Vendruscolo,et al. From macroscopic measurements to microscopic mechanisms of protein aggregation. , 2012, Journal of molecular biology.
[45] F. Chiti,et al. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. , 2012, Chemistry & biology.
[46] J. Dordick,et al. Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid β through Three Independent Pathways* , 2010, The Journal of Biological Chemistry.
[47] M. Roitman,et al. Inhibition of PTP1B by Trodusquemine (MSI‐1436) Causes Fat‐specific Weight Loss in Diet‐induced Obese Mice , 2010, Obesity.
[48] Fabrizio Chiti,et al. A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.
[49] C. Dobson. Protein folding and misfolding , 2003, Nature.
[50] V. Subramaniam,et al. Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .
[51] R. Ahima,et al. Appetite suppression and weight reduction by a centrally active aminosterol. , 2002, Diabetes.
[52] T. Morgan,et al. Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies , 2001, Journal of neurochemistry.
[53] T. L. Chao,et al. Aminosterols from the dogfish shark Squalus acanthias. , 2000, Journal of natural products.
[54] A. Elson,et al. Protein-tyrosine Phosphatase ϵ , 1995, The Journal of Biological Chemistry.
[55] F. Chiti,et al. Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload. , 2017, Journal of Alzheimer's disease : JAD.
[56] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.